From: Does Pharmaceutical Pricing Transparency Matter? Examining Brazil’s Public Procurement System
Drug | Sample size | Time trend estimate PB | Time trend estimate SP | Adj R2 | P-value |
---|---|---|---|---|---|
Aciclovir 200 | 59 | 0.878 (0.795, 0.981) | 0.931 (0.783, 1.131) | 0.373 | <0.0001 |
Amoxicillin 500 | 207 | 1.100 (0.986, 1.268) | 0.981 (0.916, 1.058) | 0.695 | <0.0001 |
Aspirin 100 | 77 | 1.032 (0.919, 1.243) | 1.045 (0.925, 1.246) | 0.644 | <0.0001 |
Atenolol 50 | 31 | 0.939 (0.762, 1.076) | 0.966 (0.694, 1.553) | 0.09 | 0.171 |
Captopril 12,5 | 48 | 1.218 (0.998, 1.466) | 1.053 (0.703, 1.541) | 0.65 | <0.0001 |
Diazepam 5 | 54 | 1.059 (0.986, 1.186) | 0.999 (0.858, 1.178) | 0.338 | <0.0001 |
Dipyrone 500 | 269 | 1.070 (0.944, 1.260) | 0.993 (0.936, 1.052) | 0.481 | <0.0001 |
Enalapril 10 | 42 | 1.050 (0.857, 1.388) | 1.286 (0.950, 1.567) | 0.227 | 0.008 |
Fluoxetin 20 | 36 | 0.931 (0.523, 1.477) | 1.098 (0.826, 1.585) | 0.085 | 0.151 |
Furosemide 40 | 84 | 1.049 (0.921, 1.167) | 0.961 (0.789, 1.140) | 0.575 | <0.0001 |
Glibenclamide 5 | 41 | 1.074 (0.938, 1.235) | 1.201 (0.851, 2.133) | 0.22 | 0.011 |
Hydrochlorothiazide 25 | 30 | 1.237 (0.987, 2.255) | 0.856 (0.489, 1.174) | 0.371 | 0.003 |
Metformin 850 | 37 | 0.856 (0.777, 0.928) | 0.939 (0.771, 1.037) | 0.242 | 0.011 |
Omeprazol 20 | 111 | 0.862 (0.692, 1.046) | 0.967 (0.860, 1.082) | 0.368 | <0.0001 |
Paracetamol 500 | 170 | 1.146 (1.031, 1.268) | 1.074 (0.962, 1.190) | 0.735 | <0.0001 |
Propranolol 40 | 57 | 1.022 (0.860, 1.344) | 1.024 (0.826, 1.295) | 0.2 | 0.003 |
Ranitidine 150 | 105 | 1.034 (0.957, 1.115) | 1.127 (1.021, 1.246) | 0.478 | <0.0001 |
Tramadol 50 | 55 | 0.761 (0.681, 0.949) | 1.067 (0.847, 1.466) | 0.46 | <0.0001 |
Warfarin 5 | 40 | 0.837 (0.759, 0.975) | 1.035 (0.899, 1.218) | 0.626 | <0.0001 |